Skip to main content

Peer Review reports

From: CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)

Original Submission
27 May 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
31 Aug 2016 Editorially accepted
5 Sep 2016 Article published 10.1186/s12885-016-2756-5

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us